Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference
Alzheimer's & Dementia · 2024-09 · 20 (9) · 6590-6605
DOI: 10.1002/alz.13877 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 19.07.2024. Verfasst von Courtney M Kloske und 59 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer's Association, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Apolipoproteins E, Alzheimer Disease. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute of General Medical Sciences (NIGMS) Center of Biomedical Research Excellence in CNS Metabolism, BrightFocus Foundation.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION The apolipoprotein E gene ( APOE ) is an established central player in the pathogenesis of Alzheimer's disease (AD), with distinct apoE isoforms exerting diverse effects. apoE influences not only amyloid‐beta and tau pathologies but also lipid and energy metabolism, neuroinflammation, cerebral vascular health, and sex‐dependent disease manifestations. Furthermore, ancestral background may significantly impact the link between APOE and AD, underscoring the need for more inclusive research. METHODS In 2023, the Alzheimer's Association convened multidisciplinary researchers at the “AAIC Advancements: APOE” conference to discuss various topics, including apoE isoforms and their roles in AD pathogenesis, progress in apoE‐targeted therapeutic strategies, updates on disease models and interventions that modulate apoE expression and function. RESULTS This manuscript presents highlights from the conference and provides an overview of opportunities for further research in the field. DISCUSSION Understanding apoE's multifaceted roles in AD pathogenesis will help develop targeted interventions for AD and advance the field of AD precision medicine. Highlights APOE is a central player in the pathogenesis of Alzheimer's disease. APOE exerts a numerous effects throughout the brain on amyloid‐beta, tau, and other pathways. The AAIC Advancements: APOE conference encouraged discussions and collaborations on understanding the role of APOE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Alzheimer's Association, Chicago, Illinois, USA.
- Department of Neurology and Neurological Sciences, Stanford University, Stanford, Palo Alto, California, USA.
- NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, St. Louis, Missouri, USA.
- Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, USA.
- Institute for Public Health Genetics, University of Washington, Seattle, Washington, USA.
Förderung
- NIA NIH HHS
- National Institute of General Medical Sciences (NIGMS) Center of Biomedical Research Excellence in CNS Metabolism
- BrightFocus Foundation
- ODCDC CDC HHS
- TRIAD
- NIH-NIDDK Intramural Research Program
- National Institute on Aging (NIA)
- NIH HHS
Zitieren
APA
Kloske, C. M., Belloy, M. E., Blue, E. E., Bowman, G. R., Carrillo, M. C., Chen, X., Chiba-Falek, O., Davis, A. A., Paolo, G. D., Garretti, F., Gate, D., Golden, L. R., Heinecke, J. W., Herz, J., Huang, Y., Iadecola, C., Johnson, L. A., Kanekiyo, T., Karch, C. M., …, & Holtzman, D. M. (2024). Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference. Alzheimer's & Dementia, 20(9), 6590-6605. https://doi.org/10.1002/alz.13877
Vancouver
Kloske CM, Belloy ME, Blue EE, Bowman GR, Carrillo MC, Chen X, et al. Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference. Alzheimer's & Dementia. 2024;20(9):6590-6605. doi:10.1002/alz.13877
BibTeX
@article{Kloske2024,
author = {Kloske, Courtney M and Belloy, Michael E and Blue, Elizabeth E and Bowman, Gregory R and Carrillo, Maria C and Chen, Xiaoying and Chiba-Falek, Ornit and Davis, Albert A and Paolo, Gilbert Di and Garretti, Francesca and Gate, David and Golden, Lesley R and Heinecke, Jay W and Herz, Joachim and Huang, Yadong and Iadecola, Costantino and Johnson, Lance A and Kanekiyo, Takahisa and Karch, Celeste M and Khvorova, Anastasia and Koppes-den Hertog, Sascha J and Lamb, Bruce T and Lawler, Paige E and Guen, Yann Le and Litvinchuk, Alexandra and Liu, Chia-Chen and Mahinrad, Simin and Marcora, Edoardo and Marino, Claudia and Michaelson, Danny M and Miller, Justin J and Morganti, Josh M and Narayan, Priyanka S and Naslavsky, Michel S and Oosthoek, Marlies and Ramachandran, Kapil V and Ramakrishnan, Abhirami and Raulin, Ana-Caroline and Robert, Aiko and Saleh, Rasha N M and Sexton, Claire and Shah, Nilomi and Shue, Francis and Sible, Isabel J and Soranno, Andrea and Strickland, Michael R and Tcw, Julia and Thierry, Manon and Tsai, Li-Huei and Tuckey, Ryan A and Ulrich, Jason D and van der Kant, Rik and Wang, Na and Wellington, Cheryl L and Weninger, Stacie C and Yassine, Hussein N and Zhao, Na and Bu, Guojun and Goate, Alison M and Holtzman, David M},
title = {Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {9},
pages = {6590--6605},
doi = {10.1002/alz.13877}
}
EUVIMED